Jonathan I Wilde is a prominent inventor based in Burlingame, CA (US). He has made significant contributions to the field of cancer diagnostics and treatment, holding a total of 13 patents. His work focuses on molecular profiling and the development of methods for diagnosing genetic disorders and cancers, particularly thyroid cancer.

Latest Patents

Among his latest patents are innovative methods for the treatment of thyroid cancer. These inventions relate to compositions and methods for molecular profiling and diagnostics for genetic disorders and cancer. They include algorithms and methods for classifying cancer, specifically thyroid cancer, and methods for determining molecular profiles to provide accurate diagnoses. Another notable patent involves the classification of tissue samples as positive or negative for cancer. This invention encompasses compositions, kits, and methods for molecular profiling and cancer diagnostics, particularly focusing on genomic DNA markers associated with thyroid cancer.

Career Highlights

Jonathan I Wilde is currently associated with Veracyte, Inc., a company dedicated to advancing cancer diagnostics. His work at Veracyte has been instrumental in developing innovative solutions that enhance the accuracy of cancer detection and treatment.

Collaborations

Some of his notable coworkers include Giulia C Kennedy and Darya Chudova, who contribute to the collaborative efforts in advancing cancer research and diagnostics.

Conclusion

Jonathan I Wilde's contributions to cancer diagnostics and treatment through his patents and work at Veracyte, Inc. highlight his commitment to improving healthcare outcomes. His innovative methods are paving the way for more effective cancer detection and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.